Person:
DOĞAN, ELİF ECE

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
Organizational Unit
Job Title
First Name
ELİF ECE
Last Name
DOĞAN
Name
Email Address
Birth Date

Search Results

Now showing 1 - 10 of 11
  • PublicationOpen Access
    CD40 ligand and P-selectin in heterozygous Beta-thalassemia
    (2016-06-01) CIKRIKCIOGLU, Mehmet Ali; SOYTAS, Rabia Bag; KILIC, Elif; Toprak, Aybala Erek; Karatoprak, CUMALİ; Zorlu, MEHMET; Kiskac, MUHARREM; EMEGIL, Sebnem; Cetin, GÜVEN; Dogan, ELİF ECE; SEKIN, Yahya; HAMDARD, Jamshid; ÇAKIRCA, MUSTAFA; ZORLU, MEHMET; KISKAÇ, MUHARREM; ÇETİN, GÜVEN; DOĞAN, ELİF ECE; KARATOPRAK, CUMALİ
    Objective: To investigate platelet functions and measure soluble CD40 ligand, soluble P-selectin, beta-thromboglobulin and platelet factor 4 levels in the blood of heterozygous beta thalassemia patients. Methods: The cross-sectional case-control study was conducted at Bezmialem Vakif University, Istanbul, Turkey, between September 2013 and April 2014, and comprised heterozygous beta thalassemia patients who were compared with 41 gender-, age- and body mass index-matched controls for platelet function markers. The two groups were also compared for co-morbidities, smoking, and regular medications. Results: Of the 78(78.78) subjects, 50(64%) were women and 28(36%) men with an overall mean age of 39.4±12.7 years (range: 18-79 years). The mean body mass index was 26.3±4.2. The heterozygous beta thalassemia group included 37(47%) subjects [24(65%) females; 13(35%) males] while the control group had 41(53%) [26(63%) females; 15(37%) males]. Soluble CD40 ligand and soluble P-selectin were lower in the heterozygous beta thalassemia group (p=0.009; p=0.010). Beta-thromboglobulin and platelet factor 4 levels were comparable between the groups (p=0.497; p=0.507.). Conclusions: Some platelet functions may be reduced in heterozygous beta thalassemia patients, which may be related to their lower incidence of cerebral and cardiac ischaemic events.
  • PublicationMetadata only
    Protective effect of dexpanthenol against nephrotoxic effect of amikacin: An experimental study
    (2017-05-01) Dogan, ELİF ECE; ERKOC, Reha; EKINCI, Iskender; HAMDARD, Jamshid; DONER, Baris; KARATOPRAK, CUMALİ; Coban, GANİME; Ozer, Omer Faruk; Kazancioglu, RÜMEYZA; DOĞAN, ELİF ECE; KARATOPRAK, CUMALİ; ÇOBAN, GANİME; ÖZER, ÖMER FARUK; KAZANCIOĞLU, RÜMEYZA
    Background: Amikacin has the largest spectrum among aminoglycosides, its nephrotoxic effect limits its utilization. Our purpose in this study is to review the protective effect of dexpanthenol against the nephrotoxic effect of amikacin, accompanied with histopathological and biochemical parameters.
  • PublicationMetadata only
    Amikasinin nefrotoksik etkisine karşı dekspantenolun koruyucu etkisi: Deneysel bir çalışma
    (2014-10-26) DOĞAN, ELİF ECE; EKINCI, ISKENDER; HAMDARD, JAMSHID; DONER, BARIS; CIKRIKCIOGLU, MEHMET ALI; KARATOPRAK, CUMALİ; ÇOBAN, GANİME; ÖZER, ÖMER FARUK; KAZANCIOĞLU, RÜMEYZA; DOĞAN, ELİF ECE; KARATOPRAK, CUMALİ; ÇOBAN, GANİME; ÖZER, ÖMER FARUK; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    Hyperbaric oxygen therapy of olfactory dysfunction in diabetic neuropathy with type 2 diabetes mellitus and a new definition -diabetic olfactopathy-
    (2016-01-01) Dogan, ELİF ECE; Veyseller, Bayram; DOĞAN, REMZİ; AKSOY, Fadlullah; ÖZTURAN, ORHAN; TUGRUL, Selahattin; YENİGÜN, ALPER; DOĞAN, REMZI; YENİGÜN, ALPER; AKSOY, FADLULLAH; DOĞAN, ELİF ECE; ÖZTURAN, ORHAN
  • PublicationMetadata only
    Sisplatin nefrotoksisitesinin önlenmesi ve tedavisinde proxeed plus’ın etkisi: deneysel rat çalışması.
    (2017-12-22) DOĞAN, ELİF ECE; KAZANCIOĞLU, RÜMEYZA; DOĞAN, ELİF ECE; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    EFFECTS OF FASTING ON RENAL FUNCTION OF PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    (2016-05-01T00:00:00Z) Ekinci, Iskender; KAZANCIOĞLU, Rümeyza; Erkoc, Reha; Kili, Elif; DOĞAN, ELİF ECE; GÜRSU, Meltem; Cebeci, Egemen; Ozturk, Savas; KAZANCIOĞLU, RÜMEYZA; DOĞAN, ELİF ECE; GÜRSU, MELTEM
  • PublicationMetadata only
    Patients treated with therapeutic plasma exchange: A single center experience
    (2014-12-01) SAMANCI, Nilay Sengul; AYER, Mesut; Gursu, MELTEM; Ar, Muhlis Cem; YEL, Kubra; ERGEN, Abdulkadir; Dogan, ELİF ECE; KARADAG, Serhat; CEBECI, Egemen; TOPTAS, Mehmet; Kazancioglu, RÜMEYZA; OZTURK, Savas; GÜRSU, MELTEM; DOĞAN, ELİF ECE; KAZANCIOĞLU, RÜMEYZA
    Introduction: Therapeutic Plasma Exchange (TPE) is a therapeutic procedure that is used to remove high molecular weight substances from plasma. We analyzed data of patients who received TPE during the last 7 years, and focused on the efficiency of TPE in various disease groups.
  • PublicationMetadata only
    PROTECTIVE EFFECT OF DEXPANTHENOL AGAINST NEPHROTOXIC EFFECT OF AMIKACIN: AN EXPERIMENTAL STUDY
    (2015-05-01) Dogan, Elif Ece; Erkoc, Reha; Ekinci, Iskender; Hamdard, Jamshid; KARATOPRAK, CUMALİ; Cikrikcioglu, Mehmet Ali; ÇOBAN, GANİME; ÖZER, ÖMER FARUK; KAZANCIOĞLU, RÜMEYZA; DOĞAN, ELİF ECE; KARATOPRAK, CUMALİ; ÇOBAN, GANİME; ÖZER, ÖMER FARUK; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    EFFECTS OF PROXEED PLUS IN THE PREVENTION AND TREATMENT OF CISPLATIN NEPHROTOXICITY: AN EXPERIMENTAL RAT STUDY
    (2018-05-01) Dogan, ELİF ECE; Aydin, Mehmet Serif; Guler, ERAY METİN; Kocyigit, ABDÜRRAHİM; Gursu, MELTEM; Seker, MESUT; Kazancioglu, RÜMEYZA; DOĞAN, ELİF ECE; GÜLER, ERAY METİN; KOÇYİĞİT, ABDÜRRAHİM; GÜRSU, MELTEM; ŞEKER, MESUT; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    Management of Rabson-Mendenhall syndrome
    (2013-09-22) ÖZGEN, İLKER TOLGA; CESUR, YAŞAR; DEMİRKOL, DEMET; GEDİK, AHMET HAKAN; AKSU, MEHMET ŞİRİN; ÖZGEN, İLKER TOLGA; CESUR, YAŞAR; VEHAPOĞLU TÜRKMEN, AYSEL; DOĞAN, ELİF ECE; DOĞAN DEMİR, AYŞEGÜL